EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Development of the rationale of a personalized cancer vaccine based on the in situ vaccine effect of radiotherapy: a mechanistic study of the POLARSTAR trial

Kai Pang, Peilin Sun, Xinzhi Liu, Dan Yang, Pengfei Zhao, Yongjie Huang, Shun Cao, Yang Gao, Guangyong Chen, Huajing Yu, Liping Duan, Yingchi Yang und 1 weitere

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-025-04229-3 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Kai Pang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Address: No.95 of Yong'an Road, Xi'cheng District, Beijing, 1…. Hauptthemen laut MEDLINE: Cancer Vaccines, Precision Medicine, Rectal Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Postdoctoral Research Foundation, Beijing Li Huanying Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Radiotherapy induces multiple forms of tumor cell death, including immunogenic cell death (ICD) like GSDME-mediated pyroptosis and MLKL-mediated necroptosis; and ICD has been increasingly accepted as a crucial element leading to enhanced anti-tumor adaptive immunity. We aim to clarify whether a vaccine-like effect is intrinsic for radiation-induced tumor cell death, and to explore potential applications. METHODS: A randomized controlled trial was performed to validate the synergism between clinical radiotherapy and PD1 blockade in patients with resectable rectal cancer. Colorectal cancer cell lines and patient-derived organoids were used to study the impact of ionizing radiation on tumor cells. Syngeneic mouse tumor models were used to study the microenvironment modulating effect of localized irradiation, as well as the potential vaccine-like effect of the in vitro irradiated autologous tumor cells. RESULTS: For patients with locally advanced rectal cancer, adding immune checkpoint blockade to radiotherapy significantly increases tumor response rate. On cellular level, ionizing radiation induces GSDMD-mediated pyroptosis of colorectal cancer cells and increased the infiltration of cytotoxic T cells into tumor microenvironment. On syngeneic, immune-competent mouse tumor models, autologous tumor cells irradiated in vitro at a sterilization dosage work as a therapeutical vaccine to inhibit the growth of inoculated tumors. CONCLUSIONS: Radiation-elicited tumor cell death exhibited an in situ vaccine effect to potentiate immune checkpoint blockade, and autologous tumor cells irradiated in vitro at a sterilization level may serve as a candidate source of immunogen for personalized therapeutical cancer vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesPrecision MedicineRectal NeoplasmsHumansAnimalsMiceTumor MicroenvironmentFemaleMalePyroptosisCell Line, TumorColorectal NeoplasmsImmune Checkpoint InhibitorsImmunogenic Cell Death

Stichwörter der Autor:innen

Checkpoint blockadeImmunotherapyRadiationSynergismVaccine

Substanzen

Cancer VaccinesImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Address: No.95 of Yong'an Road, Xi'cheng District, Beijing, 100050, China. pk2wys@foxmail.com.
  • Department of Gastroenterology, Peking University Third Hospital, Address: No. 49 of North Garden Rd., Haidian District, Beijing, 100191, China.
  • Gastrointestinal Cancer Center, Unit III, Peking University Cancer Hospital & Institute, Beijing, China.
  • Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
  • Department of Radiotherapy, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of General Surgery, Beijing Friendship Hospital, Capital Medical University, Address: No.95 of Yong'an Road, Xi'cheng District, Beijing, 100050, China.

Förderung

  • Beijing Postdoctoral Research Foundation
  • Beijing Li Huanying Medical Foundation

Zitieren

APA

Pang, K., Sun, P., Liu, X., Yang, D., Zhao, P., Huang, Y., Cao, S., Gao, Y., Chen, G., Yu, H., Duan, L., Yang, Y., & Zhang, Z. (2025). Development of the rationale of a personalized cancer vaccine based on the in situ vaccine effect of radiotherapy: a mechanistic study of the POLARSTAR trial. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-025-04229-3

Vancouver

Pang K, Sun P, Liu X, Yang D, Zhao P, Huang Y, et al. Development of the rationale of a personalized cancer vaccine based on the in situ vaccine effect of radiotherapy: a mechanistic study of the POLARSTAR trial. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-025-04229-3

BibTeX
@article{Pang2025,
  author = {Pang, Kai and Sun, Peilin and Liu, Xinzhi and Yang, Dan and Zhao, Pengfei and Huang, Yongjie and Cao, Shun and Gao, Yang and Chen, Guangyong and Yu, Huajing and Duan, Liping and Yang, Yingchi and Zhang, Zhongtao},
  title = {Development of the rationale of a personalized cancer vaccine based on the in situ vaccine effect of radiotherapy: a mechanistic study of the POLARSTAR trial},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-025-04229-3}
}
Kostenlos starten →